




Searching News Database: Dipyridamole
HSMN NewsFeed - 27 Mar 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Additional items found! 2

Members Archive contains
2 additional stories matching:
Dipyridamole
(Password required)
Dipyridamole
(Password required)